Voloridge Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-471,872
| Closed | -$3.47M | – | 1441 |
|
|
2023
Q2 | $3.47M | Sell |
471,872
-189,900
| -29% | -$1.4M | 0.02% | 808 |
|
|
2023
Q1 | $6.86M | Buy |
661,772
+173,891
| +36% | +$1.8M | 0.03% | 571 |
|
|
2022
Q4 | $5.76M | Buy |
487,881
+195,604
| +67% | +$2.31M | 0.03% | 597 |
|
|
2022
Q3 | $6.14M | Sell |
292,277
-33,231
| -10% | -$698K | 0.03% | 582 |
|
|
2022
Q2 | $10.1M | Buy |
325,508
+32,521
| +11% | +$1.01M | 0.05% | 433 |
|
|
2022
Q1 | $12M | Buy |
292,987
+102,046
| +53% | +$4.19M | 0.07% | 361 |
|
|
2021
Q4 | $8.3M | Buy |
190,941
+1,728
| +0.9% | +$75.1K | 0.05% | 523 |
|
|
2021
Q3 | $9.47M | Sell |
189,213
-7,814
| -4% | -$391K | 0.06% | 455 |
|
|
2021
Q2 | $12.4M | Buy |
+197,027
| New | +$12.4M | 0.09% | 327 |
|
|
2020
Q4 | – | Sell |
-87,748
| Closed | -$9.07M | – | 1376 |
|
|
2020
Q3 | $9.07M | Buy |
87,748
+83,036
| +1,762% | +$8.58M | 0.08% | 280 |
|
|
2020
Q2 | $373K | Sell |
4,712
-5,871
| -55% | -$465K | ﹤0.01% | 1088 |
|
|
2020
Q1 | $612K | Buy |
10,583
+3,955
| +60% | +$229K | 0.02% | 647 |
|
|
2019
Q4 | $358K | Sell |
6,628
-26,696
| -80% | -$1.44M | 0.01% | 889 |
|
|
2019
Q3 | $1.74M | Buy |
33,324
+17,458
| +110% | +$913K | 0.03% | 493 |
|
|
2019
Q2 | $766K | Buy |
+15,866
| New | +$766K | 0.02% | 499 |
|